Prostatis Group’s Panagram AAA CLO ETF CLOX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$621K Buy
24,248
+162
+0.7% +$4.14K 0.14% 106
2026
Q1
$616K Buy
24,086
+296
+1% +$7.56K 0.16% 95
2025
Q4
$607K Buy
23,790
+7,258
+44% +$185K 0.14% 95
2025
Q3
$423K Buy
16,532
+7,555
+84% +$193K 0.11% 106
2025
Q2
$230K Buy
+8,977
New +$228K 0.07% 147

Other funds holding CLOX

Prostatis Group's CLOX Position: Q2 2026 in Review

Prostatis Group increased its Panagram AAA CLO ETF (CLOX) stake by 0.67% in Q2 2026, buying an estimated $4.14K and bringing the position to 24,248 shares worth $621K. The position accounts for 0.14% of the portfolio, ranked #106.

Prostatis Group first reported a position in CLOX in Q2 2025 and has held it in 5 quarters since. 58 funds tracked by Wall St. Rank hold CLOX as of Q2 2026.

  • Prostatis Group held 24,248 shares of Panagram AAA CLO ETF worth $621K as of Q2 2026.
  • Prostatis Group bought 162 Panagram AAA CLO ETF shares in Q2 2026, an estimated $4.14K.
  • Panagram AAA CLO ETF made up 0.14% of Prostatis Group's portfolio in Q2 2026, its #106 holding.
  • Prostatis Group first reported a position in Panagram AAA CLO ETF in Q2 2025 and has held it in 5 quarters since.
  • 58 funds tracked by Wall St. Rank held Panagram AAA CLO ETF as of Q2 2026.

Based on Prostatis Group's 13F filing for Q2 2026, filed 14 Aug 2026.